secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0001104659-23-000363
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals moves headquarters to Encinitas, CA effective Jan 1, 2023
-------------------------------------------------------------------------------

- Effective January 1, 2023, corporate headquarters relocated to 332 Encinitas Blvd, Suite 102, Encinitas, CA 92024.
- Telephone number remains unchanged at (781) 788-9043.
- Previous address was 1371 East 2100 South, Suite 200, Salt Lake City, UT 84105.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000110465923000363/0001104659-23-000363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000110465923000363/tm231320d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-000363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer